Page 7 - Repurchase Offer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

More from AP

Investegate announcements from Santhera Pharmaceuticals Holdi, Santhera Reports End Results on Convertible Bond Exchange Offer

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Santhera Reports Interim Results on Convertible Bond Exchange Offer Santhera Pharmaceuticals Holding AGApril 20, 2021 GMT NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO Pratteln, Switzerland, April 20, 2021 – Santhera Pharmaceuticals (SIX: SANN) announces that so far an aggregate principal value of around CHF 39.6 million, or 66% of its CHF 60 Million Convertible Bonds, have been accepted for exchange under the Exchange Offer announced ...

  1 In accordance with IFRS 5, the previous year's figures were retrospectively adjusted for discontinued operations. 2 Ordinary operating EBITDA corresponds to EBITDA adjusted for non-operating effects such as expenses for share-based payment, M&A activities, reorganisation, and strategic projects.   Management Board Summary "In 2020, we demonstrated to be a reliable and responsible partner in difficult times: We strengthened the relationships with our customers and created strong momentum for our continued successful growth. We have never lost sight of our strategic objectives. Through t...